Lazard Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$145M Buy
307,343
+52,362
+21% +$26.4M 0.24% 105
2025
Q4
$119M Buy
254,981
+105,521
+71% +$49M 0.2% 118
2025
Q3
$63.7M Buy
149,460
+42,539
+40% +$16.5M 0.09% 174
2025
Q2
$41M Sell
106,921
-99,872
-48% -$36M 0.06% 251
2025
Q1
$71.5M Buy
206,793
+45,078
+28% +$14.5M 0.11% 150
2024
Q4
$48.5M Buy
161,715
+27,139
+20% +$9.48M 0.07% 196
2024
Q3
$54.7M Sell
134,576
-134,668
-50% -$49.3M 0.07% 184
2024
Q2
$86.5M Buy
269,244
+54,575
+25% +$17.7M 0.11% 144
2024
Q1
$71.6M Buy
214,669
+65,926
+44% +$20.1M 0.09% 179
2023
Q4
$40.3M Sell
148,743
-52,234
-26% -$12.9M 0.05% 250
2023
Q3
$49.4M Sell
200,977
-4,772
-2% -$1.31M 0.07% 209
2023
Q2
$62.4M Buy
205,749
+3,619
+2% +$1.01M 0.08% 191
2023
Q1
$53.3M Buy
202,130
+671
+0.3% +$170K 0.07% 220
2022
Q4
$48.3M Buy
201,459
+16,979
+9% +$3.8M 0.07% 233
2022
Q3
$33.9M Buy
184,480
+64,040
+53% +$12.8M 0.05% 289
2022
Q2
$20.2M Sell
120,440
-43,791
-27% -$9.41M 0.03% 426
2022
Q1
$41.2M Sell
164,231
-84,443
-34% -$21.2M 0.05% 311
2021
Q4
$63.9M Sell
248,674
-57,732
-19% -$14.1M 0.07% 246
2021
Q3
$74.4M Sell
306,406
-23,974
-7% -$5.86M 0.08% 216
2021
Q2
$68.3M Sell
330,380
-37
-0% -$7.54K 0.08% 222
2021
Q1
$62.2M Sell
330,417
-22,973
-7% -$4.05M 0.08% 214
2020
Q4
$58.1M Sell
353,390
-11,910
-3% -$1.74M 0.07% 213
2020
Q3
$45.5M Buy
365,300
+164,288
+82% +$20.3M 0.06% 232
2020
Q2
$19.5M Sell
201,012
-99,501
-33% -$10.3M 0.03% 370
2020
Q1
$27M Sell
300,513
-15,196
-5% -$1.97M 0.05% 249
2019
Q4
$46.7M Buy
315,709
+134,948
+75% +$18.1M 0.07% 194
2019
Q3
$21.8M Buy
180,761
+90,798
+101% +$11.7M 0.04% 328
2019
Q2
$12.2M Buy
89,963
+29,590
+49% +$3.74M 0.02% 420
2019
Q1
$7.87M Buy
60,373
+38,132
+171% +$5.12M 0.01% 497
2018
Q4
$2.77M Sell
22,241
-35,358
-61% -$4.75M 0.01% 609
2018
Q3
$8.01M Sell
57,599
-185,597
-76% -$23.1M 0.01% 487
2018
Q2
$25M Sell
243,196
-161,140
-40% -$16.3M 0.04% 266
2018
Q1
$39.2M Sell
404,336
-5,390
-1% -$523K 0.07% 185
2017
Q4
$36M Buy
409,726
+88,524
+28% +$7.11M 0.06% 212
2017
Q3
$25.6M Sell
321,202
-675
-0.2% -$54.3K 0.05% 253
2017
Q2
$28.1M Buy
321,877
+768
+0.2% +$65K 0.05% 242
2017
Q1
$28.6M Buy
321,109
+173,543
+118% +$14.5M 0.05% 235
2016
Q4
$10.9M Sell
147,566
-49,616
-25% -$3.72M 0.02% 419
2016
Q3
$14.9M Sell
197,182
-93,588
-32% -$7.17M 0.03% 329
2016
Q2
$22.4M Buy
290,770
+1,955
+0.7% +$154K 0.05% 236
2016
Q1
$22.5M Buy
288,815
+30,611
+12% +$2.14M 0.05% 230
2015
Q4
$17.5M Buy
258,204
+96,291
+59% +$6.72M 0.04% 269
2015
Q3
$12.5M Buy
161,913
+40,143
+33% +$3.55M 0.03% 323
2015
Q2
$11M Buy
121,770
+3,230
+3% +$259K 0.02% 365
2015
Q1
$8.92M Buy
118,540
+45,093
+61% +$3.24M 0.02% 412
2014
Q4
$5.39M Buy
73,447
+14,726
+25% +$1.03M 0.01% 530
2014
Q3
$4.14M Buy
58,721
+42,036
+252% +$2.78M 0.01% 532
2014
Q2
$940K Buy
16,685
+12,871
+337% +$679K ﹤0.01% 721
2014
Q1
$200K Hold
3,814
﹤0.01% 819
2013
Q4
$181K Buy
+3,814
New +$176K ﹤0.01% 833

Other funds holding HCA

Lazard Asset Management's HCA Position: Q1 2026 in Review

Lazard Asset Management increased its HCA Healthcare (HCA) stake by 21% in Q1 2026, buying an estimated $26.4M and bringing the position to 307,343 shares worth $145M. The position accounts for 0.24% of the portfolio, ranked #105.

Lazard Asset Management first reported a position in HCA in Q4 2013 and has held it in 50 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Lazard Asset Management held 307,343 shares of HCA Healthcare worth $145M as of Q1 2026.
  • Lazard Asset Management bought 52,362 HCA Healthcare shares in Q1 2026, an estimated $26.4M.
  • HCA Healthcare made up 0.24% of Lazard Asset Management's portfolio in Q1 2026, its #105 holding.
  • Lazard Asset Management first reported a position in HCA Healthcare in Q4 2013 and has held it in 50 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.